"MTPA’s Radicava shows long-term benefit in ALS trials" was originally created and published by Clinical Trials Arena, a ...

Neurizon Therapeutics has reported positive topline results from an open-label extension (OLE) study of its lead candidate ...

Jodi O’Donnell-Ames founded Hope Loves Company to provide support, resources, and community to children affected by ALS.

Family, friends and colleagues braved the heat early Friday evening to pay respect to the late Brent McGee, the former ...

Summary: A new study has uncovered why some motor neurons resist degeneration in ALS while others succumb. Researchers found ...

The latest update is out from Neurosense Therapeutics Ltd. ( ($NRSN) ). As of August 20, 2025, NeuroSense Therapeutics Ltd. reported that ...

The ketamine product KETARx made by PharmaTher has been approved by the FDA for use in surgical pain management.

The Japanese launch builds on ClearStrand-ASD’s successful rollout across the United States, where it is now available in 49 states. YAC Bio will partner with hospital systems in Japan to facilitate ...

Texas senators approved several bills Monday, one of which included another attempt at blocking hemp-derived THC products.

DelveInsight's HDAC Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast report includes a ...

Having lived with an ALS diagnosis since 2018, Kate Nycz can tell you firsthand what it's like to slowly lose motor function for basic tasks. "My arm can get to maybe 90 degrees, but then it fatigues ...